| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $378.3M | +9.9% |
| Cost of Revenue | $233.7M | -4.2% |
| Gross Profit | $144.7M | +43.9% |
| R&D Expense | $6.9M | +10.3% |
| SG&A Expense | $99.0M | +4.7% |
| Operating Income | -$6.3M | +83.7% |
| Pre-tax Income | -$6.0M | +84.6% |
| Income Tax | $75K | +0.0% |
| Net Income | -$6.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.4M | +129.8% |
| Inventory | $85.3M | +16.0% |
| Current Assets | $213.9M | +35.6% |
| Total Assets | $247.4M | +22.7% |
| Current Liabilities | $59.9M | +5.6% |
| Total Liabilities | $73.1M | -6.9% |
| Stockholders' Equity | $174.3M | +41.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.5M | -92.0% |
| Capital Expenditures | $530K | -71.2% |
| Investing Cash Flow | -$530K | -113.8% |
| Financing Cash Flow | $41.6M | — |
| Free Cash Flow | $1.0M | -94.2% |
| +84.4% |
| EPS (Basic) | -$0.06 | +85.7% |
| EPS (Diluted) | -$0.06 | +85.7% |